Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,713JPY
21 Sep 2018
Change (% chg)

¥0 (+0.00%)
Prev Close
¥4,713
Open
¥4,715
Day's High
¥4,734
Day's Low
¥4,683
Volume
5,761,400
Avg. Vol
4,291,976
52-wk High
¥6,693
52-wk Low
¥4,203

Select another date:

Fri, Sep 21 2018

Photo

Takeda lung cancer drug gets European panel nod

Takeda Pharmaceutical Co's lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States.

Takeda lung cancer drug gets European panel nod

Sept 21 Takeda Pharmaceutical Co's lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States.

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

UPDATE 1-Takeda gets China's approval for $62 bln Shire purchase

* Takeda still awaiting approval from EU, Japan (Adds background, share price)

Takeda gets China's approval for $62 bln Shire purchase

Sept 14 Japan's Takeda Pharmaceutical Co Ltd said on Friday China's market regulator had approved its $62 billion acquisition of Shire Plc, bringing it closer to becoming a global top 10 drugmaker.

Takeda weighs sale of Shire's eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Sept 12 Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

Shire profit edges higher ahead of Takeda sale

LONDON Shire , the London-listed pharmaceutical group being bought by Japan's Takeda , reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to $3.92 billion, just ahead of market expectations.

Select another date: